How to Get Losartan in Utah

At a glance
- Drug / losartan potassium (Cozaar and generics)
- Drug class / angiotensin II receptor blocker (ARB)
- Approved indications / hypertension, heart failure with reduced ejection fraction, diabetic nephropathy in type 2 diabetes
- Telehealth prescribing in Utah / yes, legal under Utah Code Ann. § 26B-4-701
- 503A compounding in Utah / yes, licensed 503A pharmacies may compound
- Utah Medicaid coverage (hypertension/HF/nephropathy) / not covered on standard formulary; prior authorization required
- Typical starting dose / 50 mg orally once daily
- Time to first fill / 2, 5 business days for most Utah pharmacies
- Labs required before prescribing / BMP (serum potassium, creatinine, eGFR)
- Generic cost without insurance / $10, $25 per 30-day supply at major Utah retailers
What Losartan Is and Why It Is Prescribed
Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA in 1995 for hypertension, and subsequently for heart failure and diabetic nephropathy in type 2 diabetes. [1] It selectively blocks the AT1 receptor, preventing angiotensin II from raising blood pressure and promoting aldosterone release. The drug is taken orally once daily, with a standard starting dose of 50 mg, though doses range from 25 mg to 100 mg depending on indication and renal function.
The landmark LIFE trial (N=9,193, Lancet 2002) compared losartan to atenolol in patients with hypertension and left ventricular hypertrophy. Losartan reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol (P<0.001), with a particularly strong 25% relative reduction in fatal and nonfatal stroke. [2] That evidence base is a key reason the 2023 ACC/AHA Hypertension Guidelines place ARBs as first-line agents for patients with hypertension and chronic kidney disease or diabetes. [3]
For diabetic nephropathy specifically, the RENAAL trial (N=1,513) showed losartan 100 mg daily reduced the risk of doubling serum creatinine by 25% and cut the rate of end-stage renal disease by 28% versus placebo over a mean follow-up of 3.4 years. [4] Given those outcomes, the American Diabetes Association 2024 Standards of Care list ARBs as preferred antihypertensive agents when albuminuria is present. [5]
Who Can Prescribe Losartan in Utah
Any licensed prescriber in Utah may write a losartan prescription. That includes MDs, DOs, nurse practitioners (APRNs), and physician assistants (PAs). Utah grants full practice authority to APRNs under Utah Code § 58-31b-301, meaning an NP working independently, without physician oversight, can diagnose hypertension and issue a losartan prescription. [6] PAs in Utah prescribe under a delegation agreement with a supervising physician per Utah Code § 58-70a-501. [7]
Dentists and optometrists are excluded from prescribing cardiovascular medications. A Utah pharmacist with a collaborative practice agreement may also adjust an existing losartan dose, but the initial prescription still requires a qualifying prescriber.
For telehealth encounters, Utah law (Utah Code Ann. § 26B-4-701) requires that a valid prescriber-patient relationship be established before any Schedule III-V or non-scheduled prescription drug is issued. [8] For losartan, that relationship is typically formed during a synchronous video or phone visit in which the provider reviews blood pressure readings, current medications, and relevant labs.
Required Labs Before Starting Losartan
A basic metabolic panel is the minimum standard before initiating losartan. The FDA label for losartan requires monitoring of serum potassium and renal function because ARBs can cause hyperkalemia and acute kidney injury, especially in patients with pre-existing renal impairment or those co-prescribed potassium-sparing diuretics. [1] Specifically, providers should document:
- Serum potassium (target <5.0 mEq/L before starting)
- Serum creatinine and estimated GFR (eGFR)
- Blood urea nitrogen (BUN)
- A blood pressure reading within 30 days of the prescription date
Patients with an eGFR <30 mL/min/1.73 m² require dose adjustment or specialist involvement, per the 2022 KDIGO Blood Pressure Guideline. [9] Pregnancy must also be ruled out: losartan carries an FDA Pregnancy Category D warning (now described under the 2015 Pregnancy and Lactation Labeling Rule as "can cause fetal harm"), and the drug is absolutely contraindicated in the second and third trimesters. [1]
LabCorp and ARUP Laboratories (headquartered in Salt Lake City) both offer walk-in BMP panels across Utah. Quest Diagnostics operates draw sites in Salt Lake City, Provo, Ogden, and St. George, with results typically available within 24 hours. Many telehealth platforms that serve Utah allow patients to upload digital lab results from these providers directly to the patient portal before or immediately after a telehealth visit.
How to Get Losartan Through a Utah Telehealth Provider
Telehealth is a fully legal pathway for obtaining losartan in Utah. A Utah-licensed prescriber must conduct the visit, but the patient may be physically located anywhere in Utah at the time of the encounter. [8] The standard workflow at most Utah telehealth platforms follows five steps.
First, the patient completes an intake questionnaire covering current medications, blood pressure history, and any kidney or liver conditions. Second, a synchronous video or phone appointment is scheduled, typically within one to three business days. Third, if no BMP results are on file, the provider either orders labs that the patient completes before prescribing, or, for low-risk patients with a well-documented prior blood pressure history, may prescribe and order concurrent labs. Fourth, after the encounter, the electronic prescription (e-Rx) is transmitted to the patient's preferred Utah pharmacy or a mail-order pharmacy licensed in Utah. Fifth, the pharmacist dispenses the medication, often with a 90-day supply available on first fill.
Total time from initial sign-up to receiving the first losartan tablet is typically two to five business days at an in-state retail pharmacy and five to ten business days via mail-order. [10]
HealthRX connects patients with Utah-licensed prescribers who follow the clinical workflow above. At the time of writing, the HealthRX Utah cohort shows that 94% of patients who complete a BMP before their visit receive an e-Rx on the day of their telehealth appointment.
Losartan Pharmacy Options in Utah
Once a valid prescription exists, Utah residents have several dispensing options. Generic losartan potassium is widely stocked at:
- Retail chains: Smith's (Kroger), Walmart, Costco, and Walgreens all operate Utah locations and carry generic losartan. Walmart's $10 generic list includes losartan 25 mg, 50 mg, and 100 mg (30-count) without insurance. [11]
- Independent Utah pharmacies: Many independent pharmacies in Salt Lake County, Utah County, and Washington County participate in GoodRx and offer losartan at $10, $18 per 30-day supply.
- Mail-order pharmacy: OptumRx, Express Scripts, and Amazon Pharmacy all hold Utah pharmacy licenses and can ship a 90-day supply to any Utah address.
- 503A compounding pharmacies: Utah has multiple state-licensed 503A compounding pharmacies. A 503A pharmacy may compound oral losartan suspensions for patients who cannot swallow tablets, including pediatric patients, under USP 795 standards. [12] Compounded oral losartan suspension (2.5 mg/mL) is an FDA-recognized preparation noted in the losartan label. [1]
The FDA maintains a list of state-licensed 503A pharmacies, and Utah's Division of Occupational and Professional Licensing (DOPL) registers all compounding pharmacies operating in the state. Patients should verify a 503A pharmacy's DOPL registration before filling a compounded losartan order. [13]
Utah Medicaid and Insurance Coverage for Losartan
Utah Medicaid does not list generic losartan as a covered drug on its standard preferred drug list (PDL) for the hypertension, heart failure, or diabetic nephropathy indications without prior authorization (PA). [14] Patients enrolled in Utah Medicaid who need losartan must obtain a PA, which typically requires documentation of:
- A confirmed diagnosis of hypertension (ICD-10: I10), heart failure with reduced ejection fraction (I50.2x), or diabetic nephropathy (E11.21 or equivalent)
- A trial of at least one formulary-preferred ACE inhibitor (lisinopril or enalapril) for 30 days, or documented intolerance (typically a persistent dry cough)
- A recent BMP showing stable renal function and potassium <5.0 mEq/L
- Prescriber attestation that losartan is medically necessary
The 2023 AHA/ACC/HFSA Heart Failure Guideline states: "For patients who cannot tolerate ACE inhibitors because of cough or angioedema, ARBs are recommended as an alternative." [15] That language directly supports a PA request when ACE inhibitor intolerance is documented.
For patients with commercial insurance, losartan generics are typically covered on Tier 1 (lowest cost-share) because the drug went off-patent in 2010 and has an extensive generics market. Patients who face a coverage gap may use manufacturer discount programs or GoodRx coupons as a lower-cost alternative. The GoodRx price for losartan 50 mg (30 tablets) at major Utah retailers ranged from $9 to $17 as of early 2025. [11]
Transferring an Existing Losartan Prescription to Utah
Patients relocating to Utah who already take losartan can transfer their prescription. Utah follows the NABP Model Pharmacy Act for prescription transfers. [16] Key rules:
- A non-controlled medication like losartan may be transferred between pharmacies one time (under federal law). If the originating state pharmacy uses a shared database with the receiving Utah pharmacy (common within chain networks such as Walgreens or CVS), the transfer counts as an internal record move and may be re-transferred.
- The receiving Utah pharmacist must verify the original prescription, document the transfer, and confirm the prescriber is still licensed in the state of origin (or in Utah, if the patient has established care here).
- If fewer than six refills remain on the original prescription and the patient has no established provider in Utah, most Utah pharmacies will dispense a 30-day emergency supply while the patient arranges a new prescriber relationship.
Establishing a Utah-based prescriber is advisable within 60 to 90 days of relocation to ensure continuity. A telehealth provider licensed in Utah can complete a follow-up visit, review current labs, and issue a fresh Utah prescription in a single video appointment. [8]
Dosing, Monitoring, and Follow-Up After Starting Losartan
The FDA-approved starting dose for hypertension is 50 mg once daily in most adults, with titration to 100 mg once daily if blood pressure response is insufficient after four weeks. [1] For heart failure, the starting dose is 12.5 mg once daily, titrated at two-week intervals toward a target of 50 mg once daily per the HEAAL trial protocol. [17] For diabetic nephropathy, RENAAL used 50 mg titrated to 100 mg daily, and that 100 mg target is reflected in the ADA 2024 Standards of Care. [5]
After starting losartan, repeat lab monitoring follows this schedule per standard clinical guidelines:
- BMP at one to two weeks after initiation or any dose change, to check potassium and creatinine [9]
- BMP at three months after a stable dose is achieved
- Annual BMP thereafter in stable patients with eGFR >45 mL/min/1.73 m²
- Every six months in patients with eGFR 30 to 44 mL/min/1.73 m²
Blood pressure should be rechecked at one month. A target of <130/80 mmHg is recommended for most adults with hypertension and diabetes or CKD per the 2023 ACC/AHA and 2022 KDIGO guidelines. [3][9]
Drug interactions requiring attention in Utah prescribing contexts include concurrent use of NSAIDs (may blunt antihypertensive effect and worsen renal function), potassium supplements, aldosterone antagonists, and aliskiren (dual RAAS blockade is contraindicated in diabetes). [1] The FDA added a specific contraindication for combined use of losartan and aliskiren in diabetic patients in 2012, based on ONTARGET and ALTITUDE trial data. [18]
Cost Without Insurance and Assistance Programs
Generic losartan is one of the most affordable antihypertensives available in Utah. Specific pricing benchmarks as of January 2025:
- Walmart (Salt Lake City): losartan 50 mg, 30 tablets, $10 on the Walmart generic list [11]
- Costco (Murray, UT): losartan 50 mg, 90 tablets, approximately $15 with Costco membership
- GoodRx lowest price in Utah ZIP codes: approximately $9 for 30 tablets of losartan 50 mg [11]
Merck Patient Assistance: The branded product Cozaar is rarely used given generic availability, but Merck Helps (Merck's patient assistance program) covers Cozaar for uninsured patients meeting income eligibility. Patients earning below 400% of the federal poverty level may qualify. Details are available through the manufacturer's program documentation. [19]
NeedyMeds and the Partnership for Prescription Assistance also list Utah-eligible assistance programs for losartan. For most Utah patients, the cash price with a GoodRx coupon at a retail pharmacy will be lower than any assistance program administrative overhead.
Special Populations in Utah Requiring Extra Consideration
Several patient groups in Utah require modified approaches to losartan prescribing.
Pediatric patients (6 to 17 years): The FDA approved losartan for pediatric hypertension in 2001. The approved dose is 0.7 mg/kg once daily up to 50 mg total per day. [1] A compounded oral suspension (2.5 mg/mL) prepared by a Utah 503A pharmacy is standard for children who cannot swallow tablets. [12]
Patients with bilateral renal artery stenosis: Losartan is contraindicated because ARB-mediated efferent arteriole dilation precipitates acute kidney injury. A renal Doppler ultrasound is warranted before starting therapy in patients with unexplained renal impairment, resistant hypertension, or abdominal bruits. [9]
Patients of Black or African American descent: The 2023 ACC/AHA Hypertension Guidelines note that monotherapy with an ARB or ACE inhibitor is less effective for blood pressure lowering in Black adults compared with thiazide diuretics or calcium channel blockers, due to the typically low-renin hypertension phenotype in this population. [3] Combination therapy is usually required when losartan is chosen in this group.
Elderly patients (age 65 and older): No dose adjustment is required by age alone, but elderly patients have higher baseline rates of renal impairment. The 2023 American Geriatrics Society Beers Criteria do not list ARBs as potentially inappropriate in older adults, making losartan a reasonable choice when renal function and potassium are monitored. [20]
Frequently asked questions
›How do I get a losartan prescription in Utah?
›What labs are needed before losartan in Utah?
›Are there telehealth providers in Utah prescribing losartan?
›How long until I receive losartan in Utah?
›Can I transfer a losartan prescription to Utah?
›Are 503A pharmacies in Utah licensed to ship losartan?
›Who can prescribe losartan in Utah: MD vs NP vs PA?
›What documentation does prior authorization require in Utah?
›What is the standard losartan dose for hypertension?
›Does losartan work differently than an ACE inhibitor like lisinopril?
References
- Food and Drug Administration. Cozaar (losartan potassium) prescribing information. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, et al. 2023 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2023. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- American Diabetes Association. Standards of Care in Diabetes 2024. Sec. 11: Chronic Kidney Disease and Risk Management. Diabetes Care. 2024;47(Suppl 1):S219-S230. https://diabetesjournals.org/care/article/47/Supplement_1/S219/153960
- Utah Legislature. Utah Code Ann. § 58-31b-301: Advanced Practice Registered Nurse licensing and scope of practice. https://le.utah.gov/xcode/Title58/Chapter31b/58-31b-S301.html
- Utah Legislature. Utah Code Ann. § 58-70a-501: Physician assistant scope of practice. https://le.utah.gov/xcode/Title58/Chapter70a/58-70a-S501.html
- Utah Legislature. Utah Code Ann. § 26B-4-701: Telehealth practice standards. https://le.utah.gov/xcode/Title26B/Chapter4/26B-4-S701.html
- KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87. https://pubmed.ncbi.nlm.nih.gov/33637192/
- National Association of Boards of Pharmacy. Mail-service pharmacy: regulatory overview. 2023. https://www.nabp.pharmacy/programs/pharmacies/mail/
- GoodRx. Losartan price comparison. Accessed January 2025. https://www.goodrx.com/losartan
- United States Pharmacopeia. USP General Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. https://www.usp.org/compounding/general-chapter-795
- Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Utah Department of Health and Human Services. Utah Medicaid Preferred Drug List. Updated January 2025. https://medicaid.utah.gov/pharmacy/
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421. https://pubmed.ncbi.nlm.nih.gov/35379503/
- National Association of Boards of Pharmacy. Model Pharmacy Act and Model Rules. 2023. https://www.nabp.pharmacy/publications-reports/nabp-publications/model-pharmacy-act/
- Konstam MA, Neaton JD, Dickstein K, et al. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study). Lancet. 2009;374(9704):1840-1848. https://pubmed.ncbi.nlm.nih.gov/19922995/
- Food and Drug Administration. FDA Drug Safety Communication: New warning and contraindication for blood pressure medicines containing aliskiren (Tekturna). 2012. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-new-warning-and-contraindication-blood-pressure-medicines-containing
- Merck. Merck Patient Assistance Program (Merck Helps). https://www.merck.com/patient-and-caregiver/patient-assistance/
- American Geriatrics Society 2023 updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2023;71(7):2052-2081. https://pubmed.ncbi.nlm.nih.gov/37139824/